CLN3 Antibody (Center) Blocking peptide
€363.00
In stock
SKU
AC-BP13304c
Background:
This gene encodes a protein that is involved in lysosomalfunction. Mutations in this, as well as other neuronalceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseasescommonly known as Batten disease or collectively known as neuronalceroid lipofuscinoses (NCLs). Many alternatively spliced transcriptvariants have been found for this gene.
Other Names:
Battenin, Batten disease protein, Protein CLN3, CLN3, BTS
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13304c was selected from the Center region of CLN3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CLN3 (HGNC:2074)
Gene ID: 1201
Primary Accession: Q13286
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
This gene encodes a protein that is involved in lysosomalfunction. Mutations in this, as well as other neuronalceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseasescommonly known as Batten disease or collectively known as neuronalceroid lipofuscinoses (NCLs). Many alternatively spliced transcriptvariants have been found for this gene.
Other Names:
Battenin, Batten disease protein, Protein CLN3, CLN3, BTS
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13304c was selected from the Center region of CLN3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CLN3 (HGNC:2074)
Gene ID: 1201
Primary Accession: Q13286
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review